Defunct Company
Total Trials
24
As Lead Sponsor
23
As Collaborator
1
Total Enrollment
3,778
NCT01916629
Photocil (Topical) for the Treatment of Psoriasis Vulgaris
Phase: N/A
Role: Lead Sponsor
Start: Aug 31, 2013
Completion: Dec 31, 2014
NCT01992172
Photocil (Topical) for the Treatment of Atopic Dermatitis
NCT01992185
Photocil (Topical) for the Treatment of Vitiligo
NCT02198261
Minoxidil Response Testing in Males With Androgenetic Alopecia
Start: Jul 31, 2014
Completion: Oct 31, 2018
NCT02206802
Minoxidil Response Testing in Females With Female Pattern Hair Loss
NCT03592121
Study to Investigate the Effect of AB-101 in Breast Cancer Survivors
Phase: Early Phase 1
Start: Jul 9, 2018
Completion: Oct 12, 2019
NCT04368897
In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity
Start: May 1, 2020
Completion: Dec 1, 2022
NCT04379583
HairDx Analytical Validation Study
Start: Jun 15, 2020
Completion: Dec 6, 2021
NCT04530500
COVID-19 In-vitro Diagnostic Test and Androgen Receptor Gene Expression
Role: Collaborator
Start: Aug 13, 2020
Completion: Dec 1, 2023
NCT04446429
Anti-Androgen Treatment for COVID-19
Start: Oct 21, 2020
Completion: Jan 21, 2021
NCT04853134
Proxalutamide Treatment for COVID-19 Female Outpatients
Phase: Phase 3
Start: Nov 1, 2020
Completion: Dec 1, 2021
NCT04728802
Proxalutamide Treatment for Hospitalized COVID-19 Patients
Start: Feb 1, 2021
Completion: Apr 15, 2021
NCT04853927
Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit
Start: Feb 8, 2021
Completion: Dec 31, 2021
NCT04986176
HC-1119 Adjuvant Treatment for Hospitalized COVID-19 Patients
Start: Apr 15, 2022
Completion: Dec 31, 2022
NCT05507372
Treatment for Post Acute COVID-19 Syndrome
Start: Oct 1, 2022
NCT06095739
Study to Investigate the Effectiveness of a Topical Cosmetic Formulation DA-OTC-002
Start: Nov 18, 2022
Completion: Jan 2, 2023
NCT05016284
Comparison of JW-100 and EUCRISA for the Treatment of Atopic Dermatitis
Start: Nov 24, 2022
Completion: Dec 15, 2022
NCT06484881
Clinical Study of Probiotic Treatment for Androgenetic Alopecia
Start: Sep 15, 2024
Completion: Oct 10, 2024
NCT06501924
Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss
Start: Jan 15, 2025
Completion: Dec 12, 2025
NCT06745336
Clinical Study of CS-001 As a Treatment for Canities (Grey Hair)
Start: Jun 15, 2025
Completion: Sep 15, 2027
NCT07033845
Pharmacokinetic Study of Topical Phenylephrine
Start: Jun 30, 2025
Completion: Dec 28, 2025
NCT06648850
Clinical Study of DA-001 as a Treatment for Telogen Effluvium
Start: Oct 1, 2025
Completion: Apr 17, 2026
NCT07166354
Clinical Study of mTOR Inhibitor as a Treatment for Grey Hair (Canities)
Phase: Phase 1/2
NCT06762548
Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia
Start: Oct 10, 2025
Completion: Nov 6, 2026